Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory … – GlobeNewswire (press release)
|
Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR–T Stem Cell Memory …
GlobeNewswire (press release) SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, provided an overview of its non-viral piggyBac™ DNA Modification … |
